The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction risks of its drugs, particularly OxyContin (oxycodone). Many other creditors ...

“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice president for ...